24 Feb 2023
10:30-11:30 am
Inauguration of the 20th BioAsia Convention

Inauguration of the 20th BioAsia Convention by:
Shri. KT Rama Rao, Hon’ble Minister for Industries & Commerce, Government of Telangana

Guests of Honour:
Dr. VK Paul, Hon'ble Member (Health), NITI Aayog
Dr. Vas Narasimhan, CEO, Novartis

Mr. Jayesh Ranjan IAS, Principal Secretary (I&C), Govt of Telangana

11:30-12:00 pm
Dr. Vas Narsimhan (CEO, Novartis)
Keynote Address: Dr. Vas Narasimhan, CEO, Novartis, Switzerland
12:00-1:30 pm
Panel Discussion - Operationalizing the "One Health" approach: Nexus of science, indigenous knowledge, policy
  • Importance of cross-sectoral collaboration: what are the expectations from each part of the ecosystem (what role are they expected to play/what contribution can they make)?
  • What policy enablement would encourage 'One Health' approach?
  • How to operationalize the 'One Health' approach in India?
Plenary Talk: Dr. Richard Hatchett, CEO, CEPI, UK (10 mins)


Chair: Dr. VK Paul, Hon'ble Member (Health), NITI Aayog

  • Dr. Richard Hatchett, CEO, CEPI, UK
  • Dr. Samit Hirawat, Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb, USA
  • Ms. Cynthia McCaffrey, UNICEF Representative to India
  • Dr. Mahender Nayak, Head of Asia Pacific, Takeda Pharmaceuticals, Singapore
  • Dr. Sai D. Prasad, Executive Director, Bharat Biotech International Ltd.

Moderator: Dr. Gagandeep Kang, Virologist and Professor, Dept. of Gastrointestinal Sciences, CMC Vellore

1:30–2:30 pm
Networking Lunch & Visit to the Exhibition
2:30–3:45 pm
this-also-new-1-3-1-1-1-1-removebg-preview (1)
Panel Discussion - Healthcare for all: Successes, challenges, and what next?
  • Where are we on our journey of achieving Universal Healthcare (recognizing the success thus far, discussing future action plan)?
  • How can we strengthen the healthcare infrastructure/resources availability (personnel and physical)?
  • What role can digital/ technology and data (e.g. real world data) play in improving healthcare access and outcome?
  • How can we increase focus on preventive healthcare in India (insurance, awareness in masses, behavior/mindset of population and healthcare system, focus on nutrition for all)?
  • What new innovative and sustainable financing mechanisms can be explored?
  • Global best practices/case studies on use of digital, improving patient awareness/experience, innovative financing mechanisms, and achieving Universal Healthcare.
  • Dr. Basant Garg IAS, Additional CEO, National Health Authority (NHA)
  • Dr. Shyam Bishen, Head, Shaping the Future of Health and Healthcare, Member of Executive Committee, World Economic Forum
  • Prof. K. Srinath Reddy, Honorary Distinguished Professor and Goodwill Ambassador, Public Health Foundation of India
  • Mr. Annaswamy Vaidheesh, CEO, North star Asia LLP
  • Dr. Prem Pavoor, Senior Partner, Head of India & Healthcare Investments, Eight Roads Ventures
  • Mr. Uday Bose, Head of Human Pharma Global Go-To-Market and Business Steering, Boehringer Ingelheim, Germany
  • Mr. Simpson Emmanuel, CEO & Managing Director, Roche Pharma India

Moderator: Mr. Vikas Dandekar, Editor - Pharma and Life Sciences, ET Prime

3:50–4:45 pm
Panel Discussion - Healthcare reimagined: Telemedicine, wearables, and healthcare in the METAVERSE
  • Changes in patient’s journey/healthcare experience due to digital technology?
  • Next generation remote health care models: home healthcare, virtual clinics (healthcare anywhere, anytime)?
  • Metaverse – new possibilities and realities?
  • Mr. Agam Upadhyay, SVP, Chief Technology Officer, GSK, USA
  • Mr. Philippe Houben, Head of GTM and Digital transformation - IMETA, Boehringer Ingelheim, UAE

Moderator: Mr. Ram Deshpande, Partner, Digital Transformation, EY

4:45–5:45 pm
Networking Break & Visit to the Exhibition
Presentation of the Genome Valley Excellence Award 2023 followed by Keynote Address:
Prof. Robert S. Langer, David H. Koch Institute Professor, Massachusetts Institute of Technology, USA
6:10-7:30 pm
1-4-1-copy-1-1-copy-2-2-1-315x315-1-removebg-preview (1)
CEO Conclave Panel Discussion
Future growth driver: What's next for India?

India continues to strengthen its foothold in the pharmaceutical industry – country’s leadership in generics was established long back, and COVID vaccines demonstrate industry’s success in rapid innovation capabilities.

What could drive the future growth for Indian pharmaceutical industry?

  • China plus one opportunity
  • Overcoming the uncertainty of global markets
  • Encouraging policy for enabling innovation and self-sustenance in KSMs and API (e.g., research linked incentives/RLI)
  • Further strengthen presence in biosimilars market
  • Contextualizing new areas (e.g. mRNA technology, CAR-T) to India and emerging markets

Chair: Mr. KT Rama Rao, Hon. Minister of I&C, Government of Telangana

  • Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories
  • Mr. Ajay Piramal, Chairman, Piramal Group
  • Ms. Mahima Datla, Managing Director, Biological E Ltd.
  • Mr. Glenn Saldanha, MD and CEO, Glenmark Pharmaceuticals
  • Mr. Hari S Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group

Moderator: Ms. Shereen Bhan, Managing Editor, CNBC-TV18

CEO Conclave Sponsor

7:30 pm
Networking Reception (Only for Invitees)

Business cocktail parties are a great opportunity to break out of your shell.



25 Feb 2023
10:30-11:15 am
Fireside chat

Dr. Sumbul Desai, VP Health, Apple, USA

Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, India

11:20-12:25 pm
2-2-new-1-copy-1-1-1-1-315x315 copy
Panel Discussion - Data, analytics and technology to transform drug R&D: Redefining innovation
  • Benefits of using data analytics and technology across the R&D process, i.e. drug discovery to clinical trials (improved productivity and efficiency)
  • Potential of new technology platforms, e.g. cell & gene therapy, stem cell therapy, CRISPR, oncolytic viruses, RNAi
  • Success stories and challenges from Indian industry
  • Global best practices in R&D to develop, manufacture and supply innovative medicines
  • Importance of partnerships and collaborations
  • Opportunities for India pharma industry (including small biotechs and CRO)
  • Dr. S. Chandrasekhar, Secretary to the Government of India, Department of Science & Technology
  • Mr. Sauri Gudlavalleti, COO, Sai Life Sciences
  • Dr. Christine Durinx, Managing Director, VIB, Belgium
  • Mr. Mahesh Bhalgat, COO, Syngene
  • Dr. Arun Anand, COO, Immuneel Therapeutics
  • Prof. Rahul Purwar, Associate Professor – IIT Bombay, CEO & Founder, ImmunoACT

Moderator: Dr. Narendra Chirmule, Founder-director, SymphonyTech Biologics

Co-moderator: Ms. Anju Ghangurde, Executive Editor, Scrip

Session Sponsor

12:30-1:30 pm
Panel Discussion - India for India and India for world: Where does quality stand?
  • What challenges we face today in India regarding drug and device quality/quality perception?
  • What have we done to increase focus on drug and devices quality and how successful have we been?
  • What more needs to be done?
  • What are the real issues and how can we address those (e.g., infrastructure and people/training/culture investments to establish right quality frameworks, and establish quality by design?)
  • Will digital transformation help?
  • What other urgent initiatives do we need to take?
  • Mr. Mark Abdoo, Associate Commissioner for Global Policy and Strategy, US FDA
  • Dr. Carmelo Rosa, Director, Division of Drug Quality, CDER, US FDA
  • Dr. Sarah McMullen, Country Director - India, FDA
  • Prof. Sarfaraz K. Niazi, Adj. Professor of Pharmaceutical Sciences, University of Illinois, Chicago, USA
  • Mr. Ian White, Executive Director, NSF Health Sciences and Former GMDP Inspector, MHRA UK
  • Mr. Pavan Kumar Mocherla, EVP & President Greater Asia, BD
  • Mr. Michael Cutter, Chief Quality Officer, Biocon Biologics Ltd.

Moderator: Ms. Ekta Batra, Anchor & Associate Editor Research, CNBC-TV18

2:30–3:30 pm
2-4-copy-1-1-1-1-removebg-preview (4)
Panel Discussion - Med-tech penetration: What is the way ahead?
  • India has been strong in frugal innovation as also evidenced by some innovative COVID diagnostics: how can India continue to build strength?
  • Digital therapeutics (e.g. sensor and AI-based diagnostics and treatment) – with the inherent IT strength, how can India make it big in this space?
  • When and how will India foray into complex and innovative medical devices?
  • What are the regulatory transformation requirements?
  • Mr. Michael Blackwell, Vice President & Managing Director – India, Medtronic
  • Mr. Bhargav Kotadia, MD, Sahajanand Medical Technologies Ltd.
  • Mr. Shishir Agarwal, Managing Director, Terumo India Pvt. Ltd.
  • Mr. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD)
  • Mr. Nikhil Srivastava, Managing Director, PAG

Session Sponsor

3:35–4:35 pm
this-also-new-1-3-1-1-1-1-removebg-preview (1)
Panel Discussion - Integrated Healthcare: the future of care delivery model

Globally, all healthcare systems are moving towards Integrated healthcare to improve overall health outcomes for patient and reduce healthcare costs.

  • Tech industry will contribute to next-generation health and the new interplay of strategic partnerships, advanced technologies, and data strategies in health care.
  • Interoperability is a very important requirement for integrated healthcare systems – what is the plan to ensure this?
  • What regulatory and policy interventions will be required for the entire ecosystem to work collaboratively, while keeping patients at the center?
  • How can technology enable providing healthcare in the hinterland? Is it easier to start integrated healthcare in the hinterland?
  • How will technology enable in drug registry and create measures to tackle counterfeit drugs?
  • Mr. Jayesh Ranjan IAS, Principal Secretary, Dept. of Industries & Commerce, Government of Telangana
  • Dr. Ramesh Byrapaneni, Managing Director, Endiya Partners
  • Mr. Jason Mitakidis, Founder, Cyclica and HealthWorks, Canada
  • Mr. Max Narr, CEO, Endosane Pharmaceuticals GmbH and Chief Investment Officer, Sanity Group, Germany
  • Mr. Alok Joshi, CEO, ABCD Technologies
  • Mr. Sanjeev Malhotra, CEO, Centre of Excellence for IOT & AI, NASSCOM

Moderator: Mr. Suresh Subramanian, Partner and National Life Sciences Leader, EY

4:40-5:40 pm
Panel Discussion - Global Supply chain transformation
  • Where are we two years post COVID? How much did India actually benefit from China Plus One strategy?
  • What further investments are required?
  • What regulatory and government support is needed?
  • What role can technology play?
  • ESG/Sustainability enablement practices in relation to manufacturing/supply chain? Adopting ESG as a culture
  • Ms. S Aparna IAS, Secretary to the Government of India, Department of Pharmaceuticals
  • Mr. Manni Kantipudi,CEO,Aragen Life sciences
  • Mr. Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines Ltd.
  • Mr. Suresh Pattathil, President OPPI and MD Abbvie, India
  • Mr. Narendra Otsawal, MD, Warburg Pincus

Moderator: Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories

5:45-6:45 pm
Startup Showcase and Valedictory Ceremony

Chief Guest: Shri. KT Rama Rao, Hon’ble Minister for Industries & Commerce, Government of Telangana

7:00 pm
Gala Dinner (Only for Invitees)



26 Feb 2023
10:30–1:00 pm
Exhibition and Networking
*Programme is subject to change